Is there any successful story?
My pulmonologist says MAC is rarely cured. But I was also told that less than 30% patients can be fully cured without any reinfection, relapse or recurrence. Is there any success story that someone can successfully manage MAC without recurrence or relapse by AWC over 5 years, 10 years or 20 years? And also without any other lung infection like other bacteria or fungus?
Interested in more discussions like this? Go to the MAC & Bronchiectasis Support Group.
Again, fantastic.
You described common sense, energy, will power, knowledge, time well spent, and great accomplishments. All that makes me think of the song "I can do anything better than you" from the show "Annie Get Your Gun."
Barbara
I was successful in keeping MAC and bronchiectasis at bay for 10 years. Newest infection is pseudomonas and antibiotics plus 3 months using oscillating vest are clearing it up slowly. Bronchiectasis has now damaged both right and left lungs. I was treated with steroids for out of control asthma for 6 months before getting a bronchoscopy. First sputum sample had no organisms since the infection was so deep. I suggest everyone should remind the doctor that no organisms in sputum doesn't mean there is no underlying infection when there is a history of bronchiectasis.
Hi, Bayarea58! That was me. In 2020, while on the Big 3, I took Aerobikas and used them once a day, sterilizing when we got to a town. In 2021, I did the same for several months. In 2022, however, we had our car specifically so I could bring more airway gear/sterilizers. I brought my PariS Trek with its battery and saline on trail, and I would nebulize every morning before we left camp. We would get to town every third night as a rule, and I'd sterilize everything and charge the batteries then. We do hike typically 10 to 15 miles a day with lots of elevation, so plenty of cardio daily as well.
When we went did a 6-week trip in New Hampshire, Maine and Canada in 2023 while I was on Arikayce, we had purchased a small travel trailer because I needed to refrigerate it. I did my normal full routine every morning before we took off to hike. I sterilized my gear every day in the trailer. It worked out great!
For any backpacking trips we take going forward, I might have to bring a second battery for the PariS Trek if we were out more than 3 days, but that wouldn't be too much extra weight. Typically I will do my airway/nebulizing very early before we hit the trail the first day, then I can do two days in the woods, and on the fourth day if the batteries are dead, I can do airway once we hike out and I can plug it in. It takes a little planning, but you can usually figure the logistics out for a 4 to 5 day hike, longer if you want to carry extra weight.
Laurel
Hey!
I have a Lifestraw pitcher that I use religiously and take with me on all travels. That is the ONLY water I consume-including coffee, iced tea, even brushing my teeth. I only use nebulizer when sick and exercise is my main airway clearance.
I am 61 years old and have been into fitness my whole life, so this works for me.
Hope that helps!
Dee
Hey-
My trip was staying in a hotel for 2 nights at a time traveling non-stop—we covered 5000 miles in 18 days.. We were up at 6 AM and back at 10 PM living out of a suitcase pretty much. The hiking and exercise was my only airway clearance, that helps through my day-to-day life as well. Dee
Hello hikers.
Never having done all that it was interesting to read your posts.
Thanks for the education of some of what it entails.
Happy trails, happy hiking and enjoyable fresh air.
Barbara
Yes, follow the money!
In Wall Street News. Insmed is hoping to be what Dupixent is to asthma, or in their case what Brensocatib is to bronchiectasis. It will be the first ever pharmaceutical for bronchiectasis. A novel drug not just a change in molecule from an existing drug. Also makers of Arikayce.
Insmed issues preliminary revenue results, guidance for Arikayce
Insmed (NASDAQ:INSM) reported preliminary 2024 revenue results for its drug Arikayce and issued 2025 revenue guidance.
The drugmaker said 2024 revenue for Arikayce was approximately $363.7M, which exceeded the upper end of the company's guidance range. For 2025, Insmed (NASDAQ:INSM) is expecting global Arikayce revenue of $405M to $425M.
The drug developer said it also anticipates launching its drug brensocatib for the treatment of bronchiectasis in Q3 2025, pending FDA approval and the granting of priority review.
Insmed also now expects to report topline Phase 2 data for TPIP in patients with pulmonary arterial hypertension in mid-2025.
Topline data from a Phase 3 study of Arikayce in the treatment of MAC lung disease is expected in Q1 2026, while dosing in a study of its gene therapy INS1201 for Duchenne muscular dystrophy is expected to begin in the first half of 2025, according to a statement.
It’s been three years since I cleared MAC without antibiotics. Along the way, I had a haemophilus infection, which I successfully treated with antibiotics. I attribute my continued health not only to consistent airway clearance but also to a holistic approach to self-care—daily exercise, maintaining a BMI of 20.5, eating nutritionally dense food, and prioritizing stress reduction.
Warm regards,
Linda Esposito